CN102038975A - 中草药植物液棉纱布卫生巾 - Google Patents
中草药植物液棉纱布卫生巾 Download PDFInfo
- Publication number
- CN102038975A CN102038975A CN201010611573XA CN201010611573A CN102038975A CN 102038975 A CN102038975 A CN 102038975A CN 201010611573X A CN201010611573X A CN 201010611573XA CN 201010611573 A CN201010611573 A CN 201010611573A CN 102038975 A CN102038975 A CN 102038975A
- Authority
- CN
- China
- Prior art keywords
- sanitary towel
- chinese herbal
- herbal medicine
- chinese medicinal
- medicinal herbal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 47
- 229920000742 Cotton Polymers 0.000 title claims abstract description 33
- 239000003814 drug Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241000411851 herbal medicine Species 0.000 claims description 34
- 239000004744 fabric Substances 0.000 claims description 31
- 210000000582 semen Anatomy 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 239000007921 spray Substances 0.000 claims description 7
- 241000217407 Margaritifera Species 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 21
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 208000002193 Pain Diseases 0.000 abstract description 8
- 230000036407 pain Effects 0.000 abstract description 8
- 241000196324 Embryophyta Species 0.000 abstract description 7
- 235000006439 Lemna minor Nutrition 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 230000003821 menstrual periods Effects 0.000 abstract description 6
- 208000003251 Pruritus Diseases 0.000 abstract description 4
- 230000002147 killing effect Effects 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000007803 itching Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000002159 abnormal effect Effects 0.000 abstract description 2
- 239000008361 herbal raw material Substances 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000764073 Bistorta paleacea Species 0.000 abstract 1
- 241001660870 Cyrtomium Species 0.000 abstract 1
- 241000238631 Hexapoda Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 208000008350 Pruritus Vulvae Diseases 0.000 abstract 1
- 244000173853 Sanguisorba officinalis Species 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 238000009395 breeding Methods 0.000 abstract 1
- 230000001488 breeding effect Effects 0.000 abstract 1
- 230000000249 desinfective effect Effects 0.000 abstract 1
- 238000009499 grossing Methods 0.000 abstract 1
- 230000005906 menstruation Effects 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
- 208000015317 vulvar disease Diseases 0.000 abstract 1
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 6
- HJJPJSXJAXAIPN-UHFFFAOYSA-N arecoline Chemical group COC(=O)C1=CCCN(C)C1 HJJPJSXJAXAIPN-UHFFFAOYSA-N 0.000 description 6
- 244000207740 Lemna minor Species 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 235000001855 Portulaca oleracea Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010033799 Paralysis Diseases 0.000 description 4
- 206010046914 Vaginal infection Diseases 0.000 description 4
- 201000008100 Vaginitis Diseases 0.000 description 4
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 229920001864 tannin Polymers 0.000 description 4
- 235000018553 tannin Nutrition 0.000 description 4
- 239000001648 tannin Substances 0.000 description 4
- DNJFTXKSFAMXQF-UHFFFAOYSA-N Arecaidine Chemical compound CN1CCC=C(C(O)=O)C1 DNJFTXKSFAMXQF-UHFFFAOYSA-N 0.000 description 3
- 206010060891 General symptom Diseases 0.000 description 3
- 235000010254 Jasminum officinale Nutrition 0.000 description 3
- 240000005385 Jasminum sambac Species 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 208000006374 Uterine Cervicitis Diseases 0.000 description 3
- 206010008323 cervicitis Diseases 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229960001340 histamine Drugs 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000004441 taeniasis Diseases 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- MYDYIGNXMHUFGM-UHFFFAOYSA-N 3,4-dimethoxy-1-methyl-2h-pyridine Chemical compound COC1=C(OC)C=CN(C)C1 MYDYIGNXMHUFGM-UHFFFAOYSA-N 0.000 description 2
- MSJYXDWNWRTZON-UHFFFAOYSA-N Albaspidin Natural products CCCC(=O)C1=C(O)C(C)(C)C(=C(CC2C(O)C3(C)CC(C(=O)CCC)(C2=O)C3=O)C1)O MSJYXDWNWRTZON-UHFFFAOYSA-N 0.000 description 2
- 244000080767 Areca catechu Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- GJRJTYFSORWKBE-UHFFFAOYSA-N Aspidinol Chemical compound CCCC(=O)C1=C(O)C=C(OC)C(C)=C1O GJRJTYFSORWKBE-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010011732 Cyst Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000498255 Enterobius vermicularis Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- ZHPLIOLOHFYBKM-UHFFFAOYSA-N Methylen-bis-filicinsaeurebutanon Natural products CCCC(=O)C1C(=O)C(CC2C(=O)C(C(=O)CCC)C(=O)C(C)(C)C2=O)C(=O)C(C)(C)C1=O ZHPLIOLOHFYBKM-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- JYEJQUHSBMDABO-SYKQLJDKSA-N Pomolic acid Natural products C[C@@H]1CC[C@@]2(CC[C@H]3[C@@H]4CC[C@H]5C(C)(C)[C@@H](O)CC[C@]5(C)[C@H]4CC=C3[C@@H]2[C@]1(C)O)C(=O)O JYEJQUHSBMDABO-SYKQLJDKSA-N 0.000 description 2
- ZZTYPLSBNNGEIS-OPAXANQDSA-N Pomolic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@](O)(C)[C@H]5C4=CC[C@@H]3[C@]21C ZZTYPLSBNNGEIS-OPAXANQDSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 2
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000507 anthelmentic effect Effects 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 206010014881 enterobiasis Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- ZITLVRQXJUFZOO-UHFFFAOYSA-N filicinic acid Chemical compound CC1(C)C(O)=CC(=O)C=C1O ZITLVRQXJUFZOO-UHFFFAOYSA-N 0.000 description 2
- ZEACOKJOQLAYTD-UHFFFAOYSA-N flavan-3,3',4,4',5,5',7-heptol Chemical compound OC1C(O)C2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 ZEACOKJOQLAYTD-UHFFFAOYSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- DYPLDWLIOGXSSE-UHFFFAOYSA-N guvacoline Chemical compound COC(=O)C1=CCCNC1 DYPLDWLIOGXSSE-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 150000008130 triterpenoid saponins Chemical class 0.000 description 2
- -1 volume vitamin B1 Natural products 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LAOOXBLMIJHMFO-UHFFFAOYSA-N 1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one;hydron;chloride Chemical compound Cl.S1C2=CC=CC=C2C(=O)C2=C1C(C)=CC=C2NCCN(CC)CC LAOOXBLMIJHMFO-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000269417 Bufo Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000256054 Culex <genus> Species 0.000 description 1
- RKWHWFONKJEUEF-GQUPQBGVSA-O Cyanidin 3-O-glucoside Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 RKWHWFONKJEUEF-GQUPQBGVSA-O 0.000 description 1
- AVGPOAXYRRIZMM-UHFFFAOYSA-N D-Apiose Natural products OCC(O)(CO)C(O)C=O AVGPOAXYRRIZMM-UHFFFAOYSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-LJJLCWGRSA-N D-apiofuranose Chemical compound OC[C@@]1(O)COC(O)[C@@H]1O ASNHGEVAWNWCRQ-LJJLCWGRSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N D-apiofuranose Natural products OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- GZZPOFFXKUVNSW-UHFFFAOYSA-N Dodecenoic acid Natural products OC(=O)CCCCCCCCCC=C GZZPOFFXKUVNSW-UHFFFAOYSA-N 0.000 description 1
- 241000393483 Dryopteris crassirhizoma Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- ZHDRLFGZQZCZKX-BQOUFORSSA-N Fernene Chemical compound CC1(C)CCC[C@]2(C)C3=CC[C@@]4(C)[C@@H]5CC[C@H](C(C)C)[C@@]5(C)CC[C@]4(C)[C@H]3CC[C@H]21 ZHDRLFGZQZCZKX-BQOUFORSSA-N 0.000 description 1
- FOBMFUGLGLMWEM-UHFFFAOYSA-N Flavaspidic acid Natural products CCCC(=O)c1c(O)c(C)c(O)c(CC2C(O)C(C)(C)C(=C(C(=O)CC)C2=O)O)c1O FOBMFUGLGLMWEM-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 241000756137 Hemerocallis Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 241001500351 Influenzavirus A Species 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- DCBAVUVLEYSTPU-ZTPVQENVSA-N Isoadiantone Natural products C([C@]1(C)[C@H]2CC[C@H]34)CCC(C)(C)[C@@H]1CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H]1C(=O)C DCBAVUVLEYSTPU-ZTPVQENVSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- MFIXLWYJTVEVGO-YHGWSDCJSA-N O([C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CC[C@H]([C@@]([C@H]14)(C)O)C)C(O)=O)[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O Chemical compound O([C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CC[C@H]([C@@]([C@H]14)(C)O)C)C(O)=O)[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O MFIXLWYJTVEVGO-YHGWSDCJSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000879903 Pteria Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 241000522620 Scorpio Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 241000209501 Spirodela Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 241000053227 Themus Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- WCHBFWOEFOZHMK-MLHVESHNSA-N [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1r,2r,4as,6ar,6as,6br,8ar,10s,12ar,14bs)-1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-10-[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-ca Chemical compound O([C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CC[C@H]([C@@]([C@H]14)(C)O)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O WCHBFWOEFOZHMK-MLHVESHNSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229930189717 aspidinol Natural products 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- NHVQLOCTXSMKIX-UHFFFAOYSA-N flavaspidic acid bb Chemical compound CC1(C)C(=O)C(C(=O)CCC)=C(O)C(CC=2C(=C(C(=O)CCC)C(O)=C(C)C=2O)O)=C1O NHVQLOCTXSMKIX-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- MFIXLWYJTVEVGO-DNOHTNDQSA-N ilexoside B Natural products C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)O)C)C)[C@@H]2[C@]1(C)O)C)C(=O)O MFIXLWYJTVEVGO-DNOHTNDQSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- UZTMYBNYYOCNHL-UHFFFAOYSA-N kakisaponin B Natural products C1CC(C2(CCC3C(C)(CO)C(O)CCC3(C)C2C=C2)C)(C)C2=CC1(CCC(C)C(O)C)C(=O)OC1OC(CO)C(O)C(O)C1O UZTMYBNYYOCNHL-UHFFFAOYSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000010232 madder color Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- WCHBFWOEFOZHMK-UHFFFAOYSA-N oblonganoside H Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OCC(O)C(O)C6O)C(C)(C)C5CCC34C)C2C1(C)O)C(=O)OC1OC(CO)C(O)C(O)C1O WCHBFWOEFOZHMK-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 1
- 229960001553 phloroglucinol Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000001843 schistosomicidal effect Effects 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- IBYFOBGPNPINBU-UHFFFAOYSA-N tetradecenoic acid Natural products CCCCCCCCCCCC=CC(O)=O IBYFOBGPNPINBU-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- IBYFOBGPNPINBU-OUKQBFOZSA-N trans-2-tetradecenoic acid Chemical compound CCCCCCCCCCC\C=C\C(O)=O IBYFOBGPNPINBU-OUKQBFOZSA-N 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 230000003191 uterotonic effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
- DFKDOZMCHOGOBR-UHFFFAOYSA-N zaragozic acid A Natural products O1C(C(O)(C(O2)C(O)=O)C(O)=O)(C(O)=O)C(OC(=O)C=CC(C)CC(C)CC)C(O)C21CCC(=C)C(OC(C)=O)C(C)CC1=CC=CC=C1 DFKDOZMCHOGOBR-UHFFFAOYSA-N 0.000 description 1
- WFDGBBHAJUVQKE-UHFFFAOYSA-N ziyu-glycoside II Natural products CC1(O)CCCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OCC(O)C(O)C6O)C(C)(C)C5CCC34C)C12)C(=O)O WFDGBBHAJUVQKE-UHFFFAOYSA-N 0.000 description 1
- NHWWFKVFYNAGJV-UHFFFAOYSA-N ziyuglycoside I Natural products CC1(O)CCCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OCC(O)C(O)C6O)C(C)(C)C5CCC34C)C12)C(=O)OC7OC(CO)C(O)C(O)C7O NHWWFKVFYNAGJV-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种经中草药植物液浸泡或喷涂处理过的棉纱布卫生巾，用于浸泡或喷涂处理卫生巾的中草药植物液由珍珠母、草血竭、地榆、浮萍、贯众等中草药原料与水按比例制备而成，用该中草药植物液对棉纱布卫生巾进行浸泡或喷涂处理，待药液为卫生巾充分吸收后，烘干卫生巾，即制得成品。本发明产品具有抗菌消毒、杀虫止痒、祛瘀除痛、清热解毒、冲经通脉、调和气血、经期畅通等功效，能有效均衡女性阴道酸碱度，抑制细菌的滋生，对月经不调、痛经以及由多种外阴疾病所引起的阴痛、阴痒、肿胀、湿烂、异味等具有良好的治疗作用。除行经期外，平时佩带使用本品卫生巾对各种常见的妇科疾病也具有显著的疗效，起到内病外治和积极预防的作用。
Description
技术领域
本发明属于卫生用品技术领域，涉及一种适于女性行经期间及日常卫生护理时使用的卫生巾。
背景技术
女性由于生理结构特征的原因容易出现各种各样的妇科疾病，如月经不调、腹痛、白带多、阴道炎、外阴湿疹、外阴癣、外阴瘤、阴道囊肿、阴道滴虫、白班、宫颈糜烂、宫颈炎等，给广大妇女在生理及精神上带来很大的痛苦和烦恼，而患染这些疾病的一个主要原因是由于女性经期不卫生的因素所致。目前市场上有售的各种款型的卫生巾虽具有吸水吸湿性好、防渗漏、柔软舒适等优点，但由于其本身并不具有防病和排毒、杀毒作用，而且有些卫生巾还含有漂白剂等多种不利于人体健康的化学成分，因此不能有效地起到预防及治疗女性妇科疾病的作用。
发明内容
本发明的目的在于对现有技术存在的问题加以解决，提供一种可防治多种妇科疾病的中草药植物液棉纱布卫生巾，以减少或消除各种妇科疾病对广大女性健康的危害。
本发明所述的中草药植物液棉纱布卫生巾是一种经中草药植物液浸泡或喷涂处理过的棉纱布卫生巾，其制备方案源于祖国医学关于“内病外治”、“治病求本”等传统的辨证论治思想，是设计者通过对古今诸多医药学著述及民间验方的长期潜心研究并根据多年临床实践和现代药理学实验基础上通过悉心总结研制而获得的。用于浸泡或喷涂处理卫生巾的中草药植物液由下述重量配比的药物原料与水按1∶5～10的重量比例制备而成：
珍珠母 20～50，草血竭 20～35，
地榆 20～50，浮萍 10～30，
贯众 20～50，槟榔 10～30，
茜草根 10～30。
该中草药植物液棉纱布卫生巾的制备方法包括以下的工艺步骤：将方中各配比药物原料清洗后烘干或晒干后混合，用粉碎机粉碎，将粉碎后的药物原料与清水按1∶5～10的比例混匀溶合，静置20小时，用常规中草药提炼机提炼溶合药液，提炼后的药液用滤布过滤，制得中草药植物液；用中草药植物液对棉纱布卫生巾进行浸泡或喷涂，待药液为棉纱布卫生巾充分浸透吸收后，烘干棉纱布卫生巾；将干燥后的具有中草药成分的棉纱布卫生巾进行灭菌包装，即制得中草药植物液棉纱布卫生巾。
本发明处方中各味药物的药用成分与药理作用如下所述。
珍珠母
【成分】含碳酸钙90％以上，有机质约0.34％，尚含少量镁、铁、硅酸盐、硫酸盐、磷酸盐和氧化物。
【药理】以马氏珍珠贝的珍珠层粉末给家兔后，血中钙离子浓度，与给碳酸钙后几无差别。其30％硫酸水解产物含有白氨酸、蛋氨酸、丙氨酸、甘氨酸、谷氨酸、天门冬氨酸等氨基酸，对兔的耳壳血管及血压无作用，但能增大离体蟾蜍心跳振幅，降低离体兔肠张力，对兔有短暂的利尿作用。珍珠层4N盐酸提取液能抑制组织胺对离体豚鼠小肠的收缩作用。其乙醚提取液能抑制组织胺对肠管的收缩，防止组织胺引起豚鼠的休克及死亡；对马血清致敏的豚鼠过敏性休克虽不能防止，但对脏器过敏，如对豚鼠离体肠管、子宫的收缩，则有抑制的倾向。珍珠贝壳粉对小鼠肉瘤-180有抑制作用。
珍珠母的功效在于平肝，潜阳，定惊，止血，可用于治头眩、耳鸣、心悸、吐血、衄血、妇女血崩等症。
草血竭
【成分】草血竭根茎含混合性鞣质。
【功用主治】活血散瘀、止痛、止血。用于慢性胃炎、十二指肠溃疡、痢疾、月经不调、妇人微瘕、红崩、白带、浮肿、跌打损伤等；外用治创伤出血。
地榆
【成分】根含鞣质约17％，三萜皂甙2.5～4.0％。分离出的皂甙有：地榆糖甙I，水解后产生坡模醇酸、阿拉伯糖和葡萄糖；地榆糖甙II，水解后产生坡模醇酸和阿拉伯糖；地柿皂甙B，初步鉴定是葡萄糖醛酸的三萜皂甙。茎叶含槲皮素和山柰酚的甙，熊果酸等三萜类物质。叶含维生素C。花含矢车菊甙、矢车菊双甙压作用。
【药理】清热解毒、止血。治血痢、崩漏、肠风、痈肿、湿疹等。
浮萍
【成分】紫背浮萍含醋酸钾及氯化钾及碘、溴等物质。青萍含多量维生素B1、B2、C等水溶性维生素、木犀草素-7-β-葡萄糖甙、8-羟基木犀草素-8-β-葡萄糖甙等黄酮类及碘、溴等物质，其多糖是D-洋芫荽糖的丰富来源，尚含树脂、蜡质、甾类、叶绿素、糖、蛋白质、粘液质、鞣质等。
【药理】
①对心血管的作用：青萍水浸膏对奎宁引起衰竭的蛙心有强心作用，钙可增强之，大剂量使心脏停止于舒张期；并能收缩血管使血压上升。
②解热作用：青萍煎剂及浸剂2克/公斤，经口给予因注射伤寒混合疫苗而发热的家兔，证明有微弱的解热作用。
③其他作用：青萍抗菌、抗疟实验均为阴性，在实验室及现场对库蚊幼虫及蚊蛹有杀灭作用。
贯众
【成分】粗茎鳞毛蕨根茎主要成分为绵马素，系一种复杂的间苯三酚衍生物，能缓缓分解而产生三叉蕨素及白三叉蕨素；又含三叉蕨酚、黄三叉蕨酸、绵马次酸。另含有挥发袖、绵马鞣质、脂肪、树脂等；尚含三萜化合物羊齿烯、茉烯-b、铁线蕨酮、茉醇、茉醇-29雁齿烯等。
【药理】杀蛔、绦、蛲虫，清热，解毒，凉血，止血。治温热斑疹、肠风便血、血痢、血崩、带下、疮疡、尿血、月经过多蛔虫、饶虫、绦虫病、产后出血等。
槟榔
【成分】槟榔含生物碱0.3～0.6％、缩合鞣质15％。脂肪14％及槟榔红色素。生物碱主为槟榔碱，含量0.1～0.5％，其余有槟榔次碱、去甲基槟榔次碱、去甲基槟榔碱、槟榔副碱、高槟榔碱等。生槟榔含生物碱量比制品为高。槟榔内胚乳含儿茶精、花白素及其聚合物。槟榔含脂肪油14％，槟榔油的组成脂肪酸为：月桂酸19.5％，肉豆蔻酸46.2％，棕榈酸12.7％，硬脂酸1.6％，癸酸0.3％，油酸6.2％，亚油酸5.4％，十二碳烯酸0.3％，十四碳烯酸7.2％。槟榔所含自由氨基酸中脯氨酸超过15％，酪氨酸、苯丙氨酸和精氨酸超过10％，槟榔成熟则非蛋白氮含量减少。
【药理】
①驱虫作用：槟榔碱是有效的驱虫成分，对猪肉绦虫有较强的瘫痪作用，使全虫各部都瘫痪，对牛肉绦虫则仅能使头部和未成熟节片完全瘫痪，而对中段和后段的孕卵节片则影响不大；体外试验对鼠蛲虫也有麻痹作用；槟榔碱对蛔虫也可使之中毒而对钩虫则无影响。槟榔与雄黄、肉桂、阿魏混合的煎剂给小鼠灌服，对血吸虫的感染有一定的预防效果，但与萱草根、黄连及广木香一起用于治疗小鼠血吸虫病则无效。
②抗真菌、病毒作用：水浸液在试管内对堇色毛癣菌等皮肤真菌有不同程度的抑制作用，煎剂和水浸剂对流感病毒甲型某些株有一定的抑制作用，抗病毒作用可能与其中所含鞣质有关。
茜草根
【成分】茜草的根含紫茜素、茜素、伪紫茜素、茜草色素。
【药理】有利尿和轻度止血作用，对产妇有加强子宫收缩的作用，对金黄色与白色葡萄球菌、卡他球菌、肺炎球菌及流感杆菌等均有一定抑制作用。
由以上各中草药原料制备的植物浸泡或浸涂液全方具有抗菌消毒、杀虫止痒、祛瘀除痛、散痈消肿、清热解毒、收湿敛疮、冲经通脉、调和气血、经期畅通等功效，能有效均衡女性阴道酸碱度，抑制细菌的滋生。经该中草药植物液处理后制得的卫生巾除具有一般卫生巾舒软、透气、吸湿性好的功能外，还对月经不调、痛经以及由多种外阴疾病所引起的阴痛、阴痒、肿胀、湿烂、异味等具有良好的治疗作用。除行经期外，平时佩带使用本品卫生巾对各种常见的妇科疾病如阴道炎、外阴湿疹、外阴癣、外阴瘤、阴道囊肿、阴道滴虫、白班、宫颈糜烂、宫颈炎等也具有显著的疗效，起到内病外治和积极预防的作用。
本发明的结构科学卫生、工艺简单、产品无毒、无害、无化学成分，对使用者无痛苦及毒副作用，适合广大城乡妇女作为日常保健及治疗使用。
在本发明研制过程中，为证明本发明的治疗效果，设计者曾对根据上述方法制得的制品进行了临床方面的试验研究，并对一些接受诊治的患者进行了走访统计，结果如下所述。
一、中医诊断标准：女性生殖系内外阴病毒复杂、外阴红肿，阴道炎、湿疹、子宫糜烂、灼热疼痛，奇痒。
二、治疗使用方法：根据本人病情佩带使用本品卫生巾，平日每天两换，月经期根据实际情况置换，每30天为一个疗程。
三、疗效评定标准：参照《现代中医妇科方案》(2000年出版)及《新编中医临床手册》(2003年出版)制定：分为痊愈、显效、有效、无效四类。
①痊愈：症状完全消失，恢复正常；
②显效：症状减轻达90％以上，局部及全身症状基本消失；
③有效：病变部位好转达50％～90％，局部全身症状有所改善；
④无效：症状减轻或消失不足50％，局部及全身症状无改善。
四、治疗结果：经本发明设计者临床多年施治使用，获得显著疗效。通过对1005名患者(其中阴道炎患者506例，宫颈炎患者211例，子宫糜烂患者135例，外阴红肿患者73例，阴部疱疹80例)研究表明，本发明所述中草药清洁液，对所试验治疗病例的总有效率为100％；其中痊愈792例，显效198例，有效15例，无效0例。临床研究充分体现该中草药植物液棉纱布卫生巾具有解毒、杀菌、消炎、止痛、除湿止痒等作用，可有效保护清洁外阴、内阴、生殖系免受病菌感染，并且使用特别方便、广泛，安全无毒副作用。
具体实施方式
实施例一
1、制作用于浸泡棉纱布卫生巾的中草药植物液：取珍珠母35g、草血竭30g、地榆35g、浮萍25g、贯众30g、槟榔15g和茜草根15g，分别清洗、烘干后混合，用粉碎机粉碎，将粉碎后的药物原料与清水1315g均匀混合，静置20小时，用常规中草药提炼机提炼溶合药液，提炼后的药液用滤布过滤，制得中草药植物浸液。
2、制作本发明所述的中草药植物液棉纱布卫生巾：将棉纱布卫生巾浸泡在中草药植物浸液内，待药液为卫生巾充分浸透吸收后，烘干卫生巾；将干燥后的具有中草药成分的棉纱布卫生巾进行灭菌包装，即制得中草药植物液棉纱布卫生巾。
实施例二
1、制作用于喷涂棉纱布卫生巾的中草药植物液：取珍珠母40g、草血竭30g、地榆40g、浮萍20g、贯众35g、槟榔20g和茜草根15g，分别清洗、烘干后混合，用粉碎机粉碎，将粉碎后的药物原料与清水1300g均匀混合，静置20小时，用常规中草药提炼机提炼溶合药液，提炼后的药液用滤布过滤，制得中草药植物浸液。
2、制作本发明所述的中草药植物液棉纱布卫生巾：用中草药植物液对棉纱布卫生巾进行喷涂，喷涂量为每平方分米5ml，待药液为卫生巾充分浸透吸收后，烘干卫生巾；将干燥后的具有中草药成分的棉纱布卫生巾进行灭菌包装，即制得中草药植物液棉纱布卫生巾。
Claims (1)
1.一种中草药植物液棉纱布卫生巾，其特征在于它是一种经中草药植物液浸泡或喷涂处理过的棉纱布卫生巾，所说的中草药植物液由下述重量配比的药物原料与水按1∶5～10的重量比例制备而成：
珍珠母 20～50，草血竭 20～35，
地榆 20～50，浮萍 10～30，
贯众 20～50，槟榔 10～30，
茜草根 10～30；
用于制备该中草药植物液棉纱布卫生巾的方法包括以下的工艺步骤：将方中各配比药物原料清洗后烘干或晒干后混合，用粉碎机粉碎，将粉碎后的药物原料与清水按1∶5～10的比例混匀溶合，静置20小时，用常规中草药提炼机提炼溶合药液，提炼后的药液用滤布过滤，制得中草药植物液；用中草药植物液对棉纱布卫生巾进行浸泡或喷涂，待药液为卫生巾充分浸透吸收后，烘干卫生巾；将干燥后的具有中草药成分的棉纱布卫生巾进行灭菌包装，即制得中草药植物液棉纱布卫生巾。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010611573XA CN102038975A (zh) | 2010-12-29 | 2010-12-29 | 中草药植物液棉纱布卫生巾 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010611573XA CN102038975A (zh) | 2010-12-29 | 2010-12-29 | 中草药植物液棉纱布卫生巾 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102038975A true CN102038975A (zh) | 2011-05-04 |
Family
ID=43905730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010611573XA Pending CN102038975A (zh) | 2010-12-29 | 2010-12-29 | 中草药植物液棉纱布卫生巾 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102038975A (zh) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102631431A (zh) * | 2012-05-08 | 2012-08-15 | 黄华艺 | 具杀菌消炎保健功能的卫生巾药剂及制备方法 |
| CN104645405A (zh) * | 2015-03-04 | 2015-05-27 | 宁波高新区苗姑养生科技有限公司 | 一种防治阴道炎的卫生巾 |
| CN105169466A (zh) * | 2015-07-22 | 2015-12-23 | 广东妇健企业有限公司 | 一种中药卫生巾喷液 |
| CN105999374A (zh) * | 2016-07-12 | 2016-10-12 | 赵敏 | 一种孕妇适用的治疗生殖器疱疹的卫生护垫 |
| CN106110374A (zh) * | 2016-07-14 | 2016-11-16 | 李明杰 | 中草药植物液棉纱布卫生巾及其制备方法 |
| CN106139233A (zh) * | 2016-08-10 | 2016-11-23 | 厦门塔斯曼生物工程有限公司 | 一种石斛中药复方清凉抑菌护垫及其制备工艺 |
| CN106177805A (zh) * | 2016-09-05 | 2016-12-07 | 张从娥 | 一种治疗妇科疾病的外用剂及其制备方法 |
| CN108273118A (zh) * | 2018-03-15 | 2018-07-13 | 广西中医药大学 | 含氧化石墨烯-铜银纳米复合物的中药抗菌卫生巾 |
| CN108434509A (zh) * | 2018-03-15 | 2018-08-24 | 广西中医药大学 | 可拆卸含氧化石墨烯-铜银纳米复合物的中药抗菌纸尿裤 |
| CN108904137A (zh) * | 2018-05-27 | 2018-11-30 | 肖军威 | 一种卫生巾芯片的制备方法及卫生巾芯片的加工设备 |
-
2010
- 2010-12-29 CN CN201010611573XA patent/CN102038975A/zh active Pending
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102631431A (zh) * | 2012-05-08 | 2012-08-15 | 黄华艺 | 具杀菌消炎保健功能的卫生巾药剂及制备方法 |
| CN104645405A (zh) * | 2015-03-04 | 2015-05-27 | 宁波高新区苗姑养生科技有限公司 | 一种防治阴道炎的卫生巾 |
| CN105169466A (zh) * | 2015-07-22 | 2015-12-23 | 广东妇健企业有限公司 | 一种中药卫生巾喷液 |
| CN105999374A (zh) * | 2016-07-12 | 2016-10-12 | 赵敏 | 一种孕妇适用的治疗生殖器疱疹的卫生护垫 |
| CN106110374A (zh) * | 2016-07-14 | 2016-11-16 | 李明杰 | 中草药植物液棉纱布卫生巾及其制备方法 |
| CN106139233A (zh) * | 2016-08-10 | 2016-11-23 | 厦门塔斯曼生物工程有限公司 | 一种石斛中药复方清凉抑菌护垫及其制备工艺 |
| CN106177805A (zh) * | 2016-09-05 | 2016-12-07 | 张从娥 | 一种治疗妇科疾病的外用剂及其制备方法 |
| CN108273118A (zh) * | 2018-03-15 | 2018-07-13 | 广西中医药大学 | 含氧化石墨烯-铜银纳米复合物的中药抗菌卫生巾 |
| CN108434509A (zh) * | 2018-03-15 | 2018-08-24 | 广西中医药大学 | 可拆卸含氧化石墨烯-铜银纳米复合物的中药抗菌纸尿裤 |
| CN108904137A (zh) * | 2018-05-27 | 2018-11-30 | 肖军威 | 一种卫生巾芯片的制备方法及卫生巾芯片的加工设备 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102038975A (zh) | 中草药植物液棉纱布卫生巾 | |
| CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
| CN101804166B (zh) | 一种治疗小儿皮炎湿疹的中药组合物 | |
| CN102145064B (zh) | 一种治疗老年性阴道炎的中药组合物及其制备方法 | |
| CN103041173B (zh) | 一种治疗皮炎、湿疹的中药外用制剂及其制备方法 | |
| CN103721131A (zh) | 一种治疗妇女慢性盆腔炎的中药栓剂及其制备方法 | |
| CN102178814B (zh) | 一种治疗滴虫性阴道炎的中药组合物及其制备方法 | |
| CN102205026A (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
| CN103751633A (zh) | 一种治疗下肢静脉曲张的中药组合物及其制备方法 | |
| CN103800772A (zh) | 一种防治阴道炎症的妇科外用洗液及其制备方法 | |
| CN104208245B (zh) | 手足癣中药药浴及制备方法 | |
| CN106804643A (zh) | 一种检验科用中药杀菌消毒液 | |
| CN102579701B (zh) | 复方蒲公英煎剂 | |
| CN105381352A (zh) | 一种治疗妇科炎症的外用中药洗液 | |
| CN100404054C (zh) | 一种煮散型中药抗菌消炎剂及其制备方法和应用 | |
| CN102772712B (zh) | 一种治疗热毒炽盛血瘀型糖尿病足的中药组合物 | |
| CN106806758A (zh) | 一种治疗痤疮的中药制剂 | |
| CN105056159A (zh) | 一种治疗猪寄生虫病的药物及其制备方法 | |
| CN103656048B (zh) | 用于治疗奶牛乳房炎的药物及其制备方法 | |
| CN108853277A (zh) | 一种用于针灸的中药消毒液 | |
| CN103721138B (zh) | 一种治疗酒糟鼻的中药外用制剂及其制备方法 | |
| CN103655735B (zh) | 一种治疗脚气、皮肤瘙痒症泡洗剂 | |
| CN106237247A (zh) | 一种治疗妇科炎症的中药组合物 | |
| KR101125758B1 (ko) | 여성 국부 청결용 세정제 조성물 | |
| CN110384785A (zh) | 一种用于治疗病毒性感冒的外用中药药液及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110504 |